13 years of historical data (2013–2025) · Basic Materials · Chemicals - Specialty
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Ingevity Corporation currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 9.3x P/FCF, 46% below the 5-year average of 17.2x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.5B | $2.1B | $1.5B | $1.7B | $2.7B | $2.9B | $3.1B | $3.7B | $3.6B | $3.0B | $2.3B |
| Enterprise Value | $3.7B | $3.3B | $2.9B | $3.2B | $4.2B | $3.9B | $4.2B | $4.9B | $4.2B | $3.4B | $2.8B |
| P/E Ratio → | -15.61 | — | — | — | 12.81 | 24.31 | 17.33 | 20.09 | 21.08 | 23.73 | 66.10 |
| P/S Ratio | 2.17 | 1.83 | 1.05 | 1.02 | 1.62 | 2.06 | 2.59 | 2.85 | 3.15 | 3.08 | 2.55 |
| P/B Ratio | 87.73 | 72.13 | 7.58 | 2.73 | 3.88 | 4.26 | 4.90 | 6.95 | 10.50 | 10.27 | 16.32 |
| P/FCF | 9.27 | 7.83 | 29.02 | 18.08 | 15.86 | 15.16 | 12.76 | 22.92 | 22.55 | 24.61 | 32.59 |
| P/OCF | 7.65 | 6.47 | 11.51 | 8.40 | 8.65 | 9.79 | 8.93 | 13.37 | 14.15 | 17.18 | 18.14 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Ingevity Corporation's enterprise value stands at 10.0x EBITDA, 15% above its 5-year average of 8.8x. The Basic Materials sector median is 11.1x, placing the stock at a 9% discount on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.83 | 2.04 | 1.87 | 2.50 | 2.82 | 3.48 | 3.76 | 3.73 | 3.45 | 3.05 |
| EV / EBITDA | 10.05 | 8.98 | 7.79 | 8.34 | 9.26 | 9.40 | 11.07 | 11.77 | 13.22 | 13.78 | 13.91 |
| EV / EBIT | 14.13 | — | — | 38.00 | 12.56 | 18.28 | 15.00 | 17.13 | 16.09 | 16.53 | 17.28 |
| EV / FCF | — | 12.09 | 56.21 | 33.18 | 24.36 | 20.69 | 17.17 | 30.20 | 26.75 | 27.54 | 38.92 |
Margins and return-on-capital ratios measuring operating efficiency
Ingevity Corporation earns an operating margin of 22.4%, above the Basic Materials sector average of 10.3%. Operating margins have expanded from 15.2% to 22.4% over the past 3 years, signaling improving operational efficiency. A negative ROE of -148.6% indicates the company is currently destroying shareholder equity. ROIC of 14.2% represents solid returns on invested capital.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 39.5% | 39.5% | 32.3% | 27.9% | 34.2% | 36.9% | 38.3% | 37.3% | 36.8% | 33.8% | 30.2% |
| Operating Margin | 22.4% | 22.4% | 18.5% | 15.2% | 20.4% | 22.1% | — | 25.4% | 23.2% | 20.9% | 17.7% |
| Net Profit Margin | -14.3% | -14.3% | -30.6% | -0.3% | 12.7% | 8.5% | 14.9% | 14.2% | 14.9% | 13.0% | 3.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -148.6% | -148.6% | -104.1% | -0.8% | 30.8% | 17.9% | 30.9% | 42.2% | 53.6% | 58.2% | 10.6% |
| ROA | -9.1% | -9.1% | -18.5% | -0.2% | 8.1% | 4.9% | 8.1% | 10.6% | 15.1% | 14.3% | 4.4% |
| ROIC | 14.2% | 14.2% | 10.7% | 9.1% | 13.2% | 13.4% | — | 18.2% | 23.9% | 24.5% | 20.5% |
| ROCE | 17.1% | 17.1% | 12.9% | 10.9% | 14.7% | 14.3% | — | 21.4% | 27.6% | 27.6% | 23.2% |
Solvency and debt-coverage ratios — lower is generally safer
Ingevity Corporation carries a Debt/EBITDA ratio of 3.4x, which is moderately leveraged (40% above the sector average of 2.4x). Net debt stands at $1.2B ($1.2B total debt minus $78M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 41.84 | 41.84 | 7.45 | 2.43 | 2.19 | 1.96 | 2.09 | 2.31 | 2.18 | 1.52 | 3.38 |
| Debt / EBITDA | 3.37 | 3.37 | 3.95 | 4.05 | 3.40 | 3.17 | 3.52 | 2.98 | 2.32 | 1.83 | 2.42 |
| Net Debt / Equity | — | 39.21 | 7.10 | 2.28 | 2.08 | 1.56 | 1.69 | 2.21 | 1.95 | 1.22 | 3.17 |
| Net Debt / EBITDA | 3.16 | 3.16 | 3.77 | 3.79 | 3.23 | 2.51 | 2.84 | 2.84 | 2.07 | 1.46 | 2.26 |
| Debt / FCF | — | 4.26 | 27.19 | 15.10 | 8.51 | 5.53 | 4.41 | 7.28 | 4.20 | 2.93 | 6.33 |
| Interest Coverage | -0.94 | -0.94 | -4.48 | 0.89 | 5.36 | 4.15 | 5.99 | 5.08 | 7.92 | 11.20 | 8.31 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.15x means Ingevity Corporation can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.60x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.81x to 1.15x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.15 | 1.15 | 1.87 | 1.81 | 2.25 | 2.70 | 2.81 | 2.15 | 2.31 | 2.40 | 2.16 |
| Quick Ratio | 0.60 | 0.60 | 1.01 | 0.96 | 1.15 | 1.80 | 1.97 | 1.16 | 1.26 | 1.36 | 1.05 |
| Cash Ratio | 0.23 | 0.23 | 0.26 | 0.26 | 0.25 | 1.02 | 1.15 | 0.26 | 0.42 | 0.57 | 0.22 |
| Asset Turnover | — | 0.71 | 0.70 | 0.65 | 0.61 | 0.56 | 0.52 | 0.60 | 0.86 | 1.05 | 1.09 |
| Inventory Turnover | 3.80 | 3.80 | 4.20 | 3.95 | 3.28 | 3.64 | 3.97 | 3.82 | 3.75 | 4.02 | 4.19 |
| Days Sales Outstanding | — | 39.76 | 44.64 | 45.51 | 54.54 | 50.21 | 50.03 | 44.10 | 39.93 | 38.44 | 38.34 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Ingevity Corporation returns 2.2% to shareholders annually primarily through share buybacks.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | 7.8% | 4.1% | 5.8% | 5.0% | 4.7% | 4.2% | 1.5% |
| FCF Yield | 10.8% | 12.8% | 3.4% | 5.5% | 6.3% | 6.6% | 7.8% | 4.4% | 4.4% | 4.1% | 3.1% |
| Buyback Yield | 2.2% | 2.6% | 0.0% | 5.3% | 5.4% | 3.8% | 2.8% | 0.2% | 1.3% | 0.2% | 0.0% |
| Total Shareholder Yield | 2.2% | 2.6% | 0.0% | 5.3% | 5.4% | 3.8% | 2.8% | 0.2% | 1.3% | 0.2% | 0.0% |
| Shares Outstanding | — | $36M | $36M | $36M | $38M | $40M | $42M | $42M | $43M | $43M | $42M |
Compare NGVT with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $3B | -15.6 | 10.0 | 9.3 | 39.5% | 22.4% | -148.6% | 14.2% | 3.4 | |
| $3B | 23.1 | 9.3 | 28.4 | 31.7% | 11.5% | 7.9% | 7.8% | 3.5 | |
| $2B | 18.5 | 9.4 | 24.2 | 27.7% | 8.8% | 9.1% | 11.2% | 0.4 | |
| $3B | -1031.9 | 12.0 | 31.1 | 36.0% | 9.4% | -0.2% | 6.6% | 3.4 | |
| $5B | 14.6 | 7.1 | 11.7 | 25.3% | 16.7% | 20.1% | 17.4% | 1.6 | |
| $615M | 12.7 | 6.6 | 95.8 | 11.4% | 4.4% | 6.2% | 4.4% | 2.6 | |
| $3B | 40.5 | 21.2 | 38.4 | 20.6% | 10.6% | 16.4% | 12.3% | 1.6 | |
| $75B | 36.5 | 23.4 | 39.4 | 44.5% | 18.1% | 22.3% | 12.7% | 2.6 | |
| $14B | 20.0 | 14.9 | 25.5 | 41.4% | 12.3% | 25.5% | 13.3% | 2.7 | |
| $7B | 71.3 | 28.2 | 24.0 | 23.0% | 9.1% | 7.9% | 6.0% | 3.4 | |
| $1B | -2.7 | 16.6 | — | 9.3% | -0.7% | -29.0% | -0.3% | 12.8 | |
| Basic Materials Median | — | 23.1 | 11.1 | 28.7 | 31.1% | 10.3% | -0.0% | 4.6% | 2.4 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 13 years · Updated daily
Total return calculator · dividends reinvested
Calculate ReturnsDollar cost averaging vs lump sum · see how regular investing compounds over time
Run the NumbersDCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationSide-by-side revenue, margins, P/E and 10-year returns vs H.B. Fuller Company.
Compare NowQuick answers to the most common questions about buying NGVT stock.
Ingevity Corporation's current P/E ratio is -15.6x. The historical average is 26.5x.
Ingevity Corporation's current EV/EBITDA is 10.0x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 10.8x.
Ingevity Corporation's return on equity (ROE) is -148.6%. The historical average is 6.0%.
Based on historical data, Ingevity Corporation is trading at a P/E of -15.6x. Compare with industry peers and growth rates for a complete picture.
Ingevity Corporation has 39.5% gross margin and 22.4% operating margin. Operating margin above 20% indicates strong pricing power and cost efficiency.
Ingevity Corporation's Debt/EBITDA ratio is 3.4x, indicating high leverage. A ratio between 2-4x is manageable but warrants monitoring.